AI Healthcare Market — $36.9B in 2025

Market-research aggregation places the 2025 AI healthcare market at approximately $36.9 billion. This is the anchor point for the 2030 projection that has become standard in industry briefings.

The 2025 figure reflects three maturing segments: diagnostic imaging AI (the bulk of the FDA-authorized device revenue), drug-discovery AI platforms (reaching inflection as AlphaFold-derived workflows enter pharma R&D budgets at scale), and clinical-documentation AI (growth driven by ambient-scribe products adopted by hospital systems).

What $36.9B does not capture well: early-stage administrative and revenue-cycle AI — revenue here is often bundled inside broader health-IT contracts and under-reported in AI-specific market sizing. Actual spend on AI-adjacent operational tooling likely exceeds reported figures.

For investors: this is a growth market, not a nascent one. Capital flows and competitive structure now matter more than category selection. The hard questions: which segments have defensible moats (data network effects, regulatory moats, clinical-workflow lock-in) versus which are commodity software wearing AI branding.

For buyers: market size signals vendor density. Diligence depth matters more than ever — the number of “AI healthcare platform” offerings per procurement process is up sharply versus three years ago.